Oxtox is bringing technology to the drugs of abuse testing market. With a focus on roadside, transport and heavy industry testing, it is using novel electrochemistry to provide cost effective solutions where speed and accuracy are essential for safety.
|
As at 31 Dec 2012 |
IP Group holding |
|
25.7% |
|
Holding represents undiluted beneficial equity interest excluding debt